Report Description

India clarithromycin market is expected to grow at a steady rate during the forecast period. Clarithromycin is an antibiotic that is derived from erythromycin inhibiting the bacterial protein synthesis by binding to the bacterial ribosomal unit. The India clarithromycin market is driven by the use of this drug in the treatment of certain bacterial infections, including lung infection, bronchitis, sinuses and ear infections, among others.  Moreover, clarithromycin can be taken by all age groups which is forecasted to positively influence the market growth. Ongoing research and developmental activities by key market players is further expected to boost the growth of India clarithromycin market through FY2026.

The India clarithromycin market is segmented based on application, form, route of administration, source, distribution channel, end user, company, and region. Based on application, the market can be segmented into strep throat, pneumonia, skin infections, respiratory infections, Lyme disease, helicobacter pylori infection, others. Among these, respiratory infections segment is expected to dominate the market in the coming years on account of high growth in the number of population having respiratory disorders. Also, the effective use of this drug for the treatment of pneumonia is expected to drive this segmental growth in the years to come.

The major players operating in the India clarithromycin market are Abbott India Ltd., Novartis India Ltd., Sun Pharmaceuticals Industries Ltd., Aurobindo Pharma Ltd., Teva API India Ltd., Wockhardt Limited, Taj Pharmaceuticals Ltd., Ajanta Pharma Ltd., Strides Pharma Science Ltd., Takeda Pharmaceuticals India Private Ltd., and others. Major companies are developing advanced technologies and launching new products in order to stay competitive in the market. Other competitive strategies include mergers & acquisitions and new product developments to expand their geographic reach and to increase their customer basis.

Years considered for this report:

Historical Years: FY2016-FY2019

Base Year: FY2020

Estimated Year: FY2021

Forecast Period: FY2022–FY2026

Objective of the Study:

  • To analyze and estimate the market size of India clarithromycin market from FY2016 to FY2019.
  • To estimate and forecast the market size of India clarithromycin market from FY2020 to FY2026 and growth rate until FY2026.
  • To classify and forecast India clarithromycin market based on application, form, route of administration, source, distribution channel, end user, company, and regional distribution.
  • To identify dominant region or segment in the India clarithromycin market.
  • To identify drivers and challenges for India clarithromycin market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in India clarithromycin market.
  • To identify and analyze the profile of leading players operating in India clarithromycin market.
  • To identify key sustainable strategies adopted by market players in India clarithromycin market.

Click here to download the sample

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of India clarithromycin market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Clarithromycin manufacturers/ suppliers/ distributors
  • Market research and consulting firms
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to clarithromycin

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, India clarithromycin market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • India Clarithromycin Market, By Application:
    • Strep throat
    • Pneumonia
    • Skin Infections
    • Respiratory Infections
    • Lyme Disease
    • Helicobacter Pylori Infection
    • Others
  • India Clarithromycin Market, By Form:
    • Tablet
    • Capsule
    • Suspension
    • Others
  • India Clarithromycin Market, By Route of Administration:
    • Oral
    • Intravenous
  • India Clarithromycin Market, By Source:
    • In-house
    • Contract Manufacturing Organizations
  • India Clarithromycin Market, By Distribution Channel:
    • Online
    • Offline
  • India Clarithromycin Market, By End User:
    • Adult
    • Paediatric
  • India Clarithromycin Market, By Region:
    • North
    • South
    • East
    • West

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in India clarithromycin market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
India clarithromycin market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]  

Table of content

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on Clarithromycin Market

4.    Executive Summary

5.    Manufacturing Clarithromycin

5.1.  Raw Material

5.2.  Machinery

5.3.  Manufacturing Methods

5.4.  Contact Details of Machinery & Raw Material Suppliers

6.    Pharmacodynamic Overview of Clarithromycin

6.1.  Mechanism of Action

6.2.  Absorption

6.3.  Volume of Distribution

6.4.  Protein Binding

6.5.  Metabolism

6.6.  Route of Elimination

6.7.  Half-Life

6.8.  Clearance

6.9.  Toxicity

7.    India Clarithromycin Market Outlook

7.1.  Market Size & Forecast

7.1.1.     By Value & Volume

7.2.  Market Share & Forecast

7.2.1.     By Application (Strep throat, Pneumonia, Skin Infections, Respiratory Infections, Lyme Disease, Helicobacter Pylori Infection, Others)

7.2.2.     By Form (Tablet, Capsule, Suspension, Others)

7.2.3.     By Route of Administration (Oral, Intravenous,)

7.2.4.     By Source (In-house v/s Contract Manufacturing Organizations)

7.2.5.     By Distribution Channel (Online v/s Offline)

7.2.6.     By End User (Adult v/s Paediatric)

7.2.7.     By Region (North, East, South, West)

7.2.8.     By Company

7.3.  Product Market Map

8.    Market Dynamics

8.1.  Drivers/Opportunities

8.2.  Challenges/Restraints

9.    Market Trends & Developments

10.  Policy & Regulatory Landscape

10.1.              Custom Duty & Taxes

10.2.              Government Subsidy & Benefits

10.3.              Relevant Policies & Regulations (GMP, USFDA, WHO Certifications)

11.  Import & Export Analysis

12.  Pricing Analysis

13.  India Economic Profile

14.  Competitive Landscape

14.1.              Company Profiles

14.1.1.  Abbott India Ltd.      Company Brief      Production Plants & Capacity (If Available)      Financials (If Available)      Captive Consumption Vs Merchant Sale      Current & Future Plans

14.1.2.  Novartis India Ltd.

14.1.3.  Sun Pharmaceuticals Industries Ltd.

14.1.4.  Aurobindo Pharma Ltd.

14.1.5.  Teva API India Ltd.

14.1.6.  Wockhardt Limited

14.1.7.  Taj Pharmaceuticals Ltd.

14.1.8.  Ajanta Pharma Ltd.

14.1.9.  Strides Pharma Science Ltd.

14.1.10.                Takeda Pharmaceuticals India Private Ltd.

15.  Strategic Recommendations

16. About Us & Disclaimer

Figures and Tables

Frequently asked questions






Sakshi Bajaal

Business Consultant
Press Release

India Clarithromycin Market to grow at Brisk rate through FY2026

Oct, 2020

Growing occurrence of bacterial infections is expected to drive the growth of India clarithromycin market during the forecast period.